IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4611-4617

  Banerjee, Arnob ^a   Rothman, Paul ^a,b  

^a Columbia University ^*  (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; INTERLEUKIN 7; PROTEIN TYROSINE KINASE;

APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOCYTE TRANSFORMATION; LYMPHOID CELL; NORTHERN BLOTTING; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVE MUTANT;

ABELSON MURINE LEUKEMIA VIRUS; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BCL-X PROTEIN; CELL CYCLE; CELL TRANSFORMATION, VIRAL; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GENES, ABL; GENES, BCL-2; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-4; INTERLEUKIN-7; JANUS KINASE 1; JANUS KINASE 3; MICE; MILK PROTEINS; NF-KAPPA B; ONCOGENE PROTEINS V-ABL; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0032213263     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Rosenberg, N. 1991. abl oncogenes. Semin. Virol. 2:365.
2. 1. Proc. Natl. Acad. Sci. USA 89:6683.
3. Engelman, A., and N. Rosenberg. 1990. bcr/abl but not myc and ras replace v-abl in lymphoid transformation. Mol. Cell. Biol. 10:4365.
4. Varticovski, L., G. Q. Daley, P. Jackson, D. Baltimore, and L. C. Cantley. 1991. Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants. Mol. Cell. Biol. 11:1107.
5. Cleveland, J., M. Dean, N. Rosenberg, J. Wang, and U. Rapp. 1989. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol. Cell Biol. 9:5685.
6. Evans, C. A., J. M. Lord, P. J. Owen-Lynch, G. Johnson, C. Dive, and A. D. Whetton. 1995. Suppression of apoptosis by v-ABL protein tyrosine kinase is associated with nuclear translocation and activation of protein kinase C in an interleukin-3-dependent haemopoietic cell line. J. Cell Sci. 108:2591.
7. c-Fes. J. Biol. Chem. 269:5764.
8. Sawyers, C. L., J. McLaughlin, and O. N. Witte. 1995. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J. Exp. Med. 181:307.
9. Chen, Y. Y., L. C. Wang, M. S. Huang, and N. Rosenberg. 1994. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev. 8:688.
10. Danial, N. N., A. Pernis, and P. B. Rothman. 1995. Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875.
11. Carlesso, N., D. A. Frank, and J. D. Griffin. 1996. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 1983:811.
12. Chai, S. K., G. L. Nichols, and P. B. Rothman. 1997. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol. 159:4720.
13. Ilaria, R. L., and R. A. Van Etten. 1996. P210 and P190BCR/ABL induce the tyrosine phosphoryiation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 271:31704.
14. Keegan, A. D., K. Nelms, L. M. Wang, J. H. Pierce, and W. E. Paul. 1994. Interleukin 4 receptor: signaling mechanisms, Immunol. Today 15:423.
15. Rich, B. E., J. Campos-Torres, R. I. Tepper, R. W. Moreadith, and P. Leder. 1993. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J. Exp. Med. 177:305.
16. Fisher, A. G., C. Burdet, C. Bunce, M. Merkenschlager, and R. Ceredig. 1995. Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential. Int. Immunol. 7:415.
17. Overell, R. W., L. Clark, D. Lynch, R. Jerzy, A. Schmierer, K. E. Weisser, A. E. Namen, and R. G. Goodwin. 1991. Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine leukemia virus transformants. Mol. Cell. Biol. 11:1590.
18. Young, J. C., M. L. Gishizky, and O. N. Witte. 1991. Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line. Mol. Cell. Biol. 11:854.
19. Schindler, C., H. Kashleva, A. Pernis, R. Pine, and P. Rothman. 1994. STF-IL-4: a novel IL-4-induced signal-transducing factor. EMBO J. 13:1350.
20. Yang, E., and S. J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386.
21. Sanchez-Garcia, I., and G. Grutz. 1995. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Proc. Natl. Acad. Sci. USA 92:5287.
22. L. Oncogene 15:2249.
23. Henriksson, M., and B. Luscher. 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:109.
24. Sawyers, C. L., W. Callahan, and O. N. Witte. 1992. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70:901.
25. Alt, F., N. Rosenberg, S. Lewis, E. Thomas, and D. Baltimore. 1981. Organization and reorganization of immunoglobulin genes in A-MuLV transformed cells: rearrangement of heavy but not light chain genes. Cell 27:381.
26. Klug, C. A., S. J. Gerety, P. C. Shah, Y. Y. Chen, N. R. Rice, N. Rosenberg, and H. Singh. 1994. The v-abl tyrosine kinase negatively regulates NFκB/Rel factors and blocks κ gene transcription in pre-B lymphocytes. Genes Dev. 8:678.
27. Duschl, A., and W. Sebald. 1996. Transmembrane and intracellular signalling by interleukin-4: receptor dimerization and beyond. Eur. Cytokine Netw. 7:37.
28. Roifman, C. M., and N. Sharfe. 1997. Differential association of phosphatidyl 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7. J. Immunol. 159:1107.
29. Venkitaraman, A. R., and R. J. Cowling. 1994. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the α chain of the interleukin-7 receptor. Eur. J. Immunol. 24:2168.
30. Zamorano, J., H. Y. Wang, R. Wang, Y. Shi, G. D. Longmore, and A. D. Keegan. 1998. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J. Immunol. 160:3502.
31. Starr, R., T. A. Willson, E. M. Viney, L. J. L. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine inducible inhibitors of signaling. Nature 387:917.
32. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921.
33. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto, 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924.
34. Henderson, A. J., R. Narayanan, L. Collins, and K. Dorshkind. 1992. Status of κL chain gene rearrangements and c-kit and IL-7 receptor expression in stromal cell-dependent pre-B cells. J. Immunol. 149:1973.
35. Rolink, A., J. Andersson, P. Ghia, U. Grawunder, D. Haasner, H. Karasuyama, E. ten Boekel, T. H. Winkler, and F. Melchers. 1995. B-cell development in mouse and man. The Immunologist 3/4:125.
36. Melamed, D., J. A. Kench, K. Grabstein, A. Rolink, and D. Nemazee. 1997. A functional B cell receptor transgene allows efficient IL-7-independent maturation of B cell precursors. J. Immunol. 159:1233.
37. Corcoran, A. E., F. M. Smart, R. J. Cowling, T. Crompton, M. J. Owen, and A. R. Venkitaraman. 1996. The interleukin-7 receptor α chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J. 15:1924.
38. Akashi, K., M. Kondo, U. von Freeden-Jeffrey, R. Murray, and I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89:1033.
39. von Freeden-Jeffrey, U., N. Solvason, M. Howard, and R. Murray. 1997. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7:147.
40. -/- mice. Cell 89:1011.
41. Armant, M., G. Delespesse, and M. Sarfati. 1995. IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. Immunology 85:331.
42. Lee, S. H., N. Fujita, T. Mashima, and T. Tsuruo. 1996. Interleukin-7 inhibits apoptosis of mouse malignant T-lymphoma cells by both suppressing the CPP32-like protease activation and inducing the Bcl-2 expression. Oncogene 13:2131.
43. Gibson, L. F., D. Piktel, R. Narayanan, G. Nunez, and K. S. Landreth. 1996. Stromal cells regulate bcl-2 and bax expression in pro-B cells. Exp. Hematol. 24:628.
44. Merino, R., L. Ding, D. J. Veis, S. J. Korsmeyer, and G. Nunez. 1994. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 13:683.
45. Cheng, E., D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno, and J. M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966.
46. Vaux, D. L., S. Cory, and J. M. Adams. 1988. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440.
47. Strasser, A., A. W. Harris, M. L. Bath, and S. Cory. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331.
48. Morrow, M. A., G. Lee, S. Gillis, G. D. Yancopoulos, and F. W. Alt. 1992. Interleukin-7 induces N-myc and C-myc expression in normal precursor B lymphocytes. Genes Dev. 6:61.
49. 1/S transition of B precursor cells. Int. Immunol. 8:317.
50. Cao, X., A. Tay, G. R. Guy, and Y. H. Tan. 1996. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 16:1595.
51. Chaturvedi, P., S. Sharma, and E. P. Reddy. 1997. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol. 17:3295.
52. Yu, C. L., D. J. Meyer, G. S. Campbell, A. C. Lamer, C. Carter-Su, J. Schwartz, and R. Jove. 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81.